- Home
- CODA vs INO Comparison
CODA vs INO Comparison
Compare CODA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODA | INO |
|---|---|---|
| Founded | 1994 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.4M | 114.0M |
| IPO Year | 2007 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CODA | INO |
|---|---|---|
| Price | $11.16 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 96.5K | ★ 2.0M |
| Earning Date | 06-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.62 | ★ 54.18 |
| EPS | ★ 0.08 | N/A |
| Revenue | $20,316,161.00 | ★ $42,220,086.00 |
| Revenue This Year | $18.28 | $20,156.19 |
| Revenue Next Year | $12.62 | $421.95 |
| P/E Ratio | $148.75 | ★ N/A |
| Revenue Growth | 4.98 | ★ 19.37 |
| 52 Week Low | $7.01 | $1.03 |
| 52 Week High | $18.00 | $2.86 |
Technical Indicators
Market Signals| Indicator | CODA | INO |
|---|---|---|
| Relative Strength Index (RSI) | 40.22 | 41.91 |
| Support Level | $10.85 | $1.03 |
| Resistance Level | $12.24 | $1.23 |
| Average True Range (ATR) | 0.75 | 0.07 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 0.00 | 19.35 |
Price Performance
Historical ComparisonAbout CODA Coda Octopus Group Inc.
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.